Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $0.3500 (14.19%) ($0.3500 - $0.3500) on Thu. Apr. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 10.35% (three month average) | RSI | 44 | Latest Price | $0.3500(14.19%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -3% a day on average for past five trading days. | Weekly Trend | ANPC declines -16.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLK(78%) IVE(66%) EWI(81%) PAVE(79%) EWP(69%) | Factors Impacting ANPC price | ANPC will decline at least -5.175% in a week (0% probabilities). SHY(-45%) BND(-34%) BNDX(-33%) VCSH(-27%) TIP(-23%) | | | | | Relative Volatility | | | | Market Trend Strength | -5.175% (StdDev 10.35%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-24.15(-7000%) | Resistance Level | $0.41 | 5 Day Moving Average | $0.32(9.37%) | 10 Day Moving Average | $0.37(-5.41%) | 20 Day Moving Average | $0.41(-14.63%) | To recent high | -61.6% | To recent low | 22.8% | Market Cap | $3m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |